News

25 Sep

Startups, be ready. Epicenter and SOE’s $10K pitch competition, The Next Big Thing, is back

In year one, Phillip Ashley Rix and his company, Phillip Ashley Chocolates, claimed victory. In year two, Lia Winter and her medical device business, Winter Innovations, took the top honor. Now year three is upon us, and the question remains — which local startup will follow in their footsteps, and be deemed “The Next Big Thing?” Called The Next Big Thing, it provides local startups and scale-ups the chance to compete for $10,000, as they make elevator pitches made […]

Portfolio News Read more...
21 Sep

Tax perks nudging employers to help pay workers’ student loans

By next year, many large companies will likely add that perk for their workers, after they’ve had time to amend their IRS Section 127 Educational Assistance Programs, said Laurel Taylor, CEO of FutureFuel.io, a company that works with employers and individuals on student loan debt. More than 70% of employers provide tuition reimbursement assistance to workers, making that a more common benefit than a 401(k) match, Taylor said. Read more >>

Portfolio News Read more...
18 Sep

Would Boston Harbor Angels Have Invested in Theranos: the Answer is, No

By Ziad H. MoukheiberPresident Boston Harbor Angels

Listening and reading about Theranos, I ask myself would Boston Harbor Angels have invested in the company?

The simple answer is no!

It is easy to say that in retrospect, however, there are some simple and fundamental reason why the group would have most likely passed on the deal.

The group invests in many companies that don’t make it or struggle but the culture of BHA leads me to say that Theranos would have not been funded by Boston Harbor Angels and this is why:

The […]

Blog Read more...
14 Sep

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics), a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes an upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to successfully developed therapeutics. Read more >>

Portfolio News Read more...
09 Sep

Canvas GFX and Aras partner to deliver integration of Aras Innovator and Canvas Envision

Canvas GFX, Inc, the leading provider of visual communication solutions to the manufacturing and technical industries today announced that it has partnered with Aras, provider of a digital transformation platform to enable the resilient enterprise to deliver an integration between Canvas Envision and the Aras innovator platform. The integration enables end users to access data stored on Aras Innovator directly from the Envision Creator desktop graphics application, allowing frictionless creation of product documentation containing rich visualizations of 3D models. […]

Portfolio News Read more...